Arcutis Biotherapeutics Inc. has announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the ...

Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Increases its competitiveness in the field of drug containment solutions and builds the largest ampoule manufacturing ...

Rivus Pharmaceuticals, Inc., announced the expansion of its leadership team and the opening of a South San Francisco office ...

Source BioScience UK Ltd, a provider of genomic services and histopathology diagnostics, has acquired Cambridge Clinical ...

Ginkgo Bioworks gains a $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems.

Prolerity Clinical Research, a clinical research site network, has appointed Stacey Johnson as its new Chief Operating ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target multiple diseases.

Curium has acquired Nucleis, a specialist in GMP manufacturing and distribution of PET radiopharmaceutical drugs.

In his new role, Chen will enhance shareholder value and guide Harbour BioMed through its next phase of strategic development ...

Batavia Biosciences, a CDMO, has pioneered a novel upstream bioprocessing method to enhance regional polio vaccine production ...